In addition to producing potent neutralizing antibodies, the candidate vaccine may not require strict temperature control. Progress toward human studies continues.
An NIH grant will help Cleveland Clinic researchers determine whether the novel dual-action agent can safely lengthen the thrombolytic time window in ischemic stroke and protect against reperfusion injury.
New elastogenic therapies based on nanotechnology could one day help women with pelvic organ prolapse.
Submicroscopic nanoparticles may help overcome the obstacles that hamper traditional anti-cancer drugs. Their size and other unique properties enable targeted drug delivery to hard-to-access tumors, as well as aiding tumor boundary visualization.